Buy Now — Best Biotech Etf To

Strategy: Market-cap weighted, dominated by giants like Vertex, Gilead, and Amgen . Expense Ratio: 0.44% . Best for: Low-cost core exposure .

Best for: Concentrated exposure to the 25 largest, most liquid biotech stocks . Strategy: Focuses on profitable blue-chip biotechs . Expense Ratio: 0.35% . best biotech etf to buy now

7 Best Biotech ETFs to Buy Now | Investing - U.S. News Money Strategy: Market-cap weighted

Strategy: Actively managed by Cathie Wood's team, targeting "disruptive" innovation . Expense Ratio: 0.75% . Comparison of Key Metrics 1-Year Return Expense Ratio Small/Mid-Cap Equal Weight IBB Large-Cap Market Weighted SBIO Clinical Trial Breakthroughs IBBQ Nasdaq Biotech Index Data based on recent 2026 market reports . dominated by giants like Vertex